162 / 1631
Site or Type
Obs
SIR
AER
All SMN
747
3.8
62.2
Solid tumors
519
2.8
37.9
Lung
155
4.3
13.4
GI tract
115
2.4
7.0
Stomach
29
2.8
2.1
Female breast
76
2.7
13.2
Thyroid
14
9.2
1.4
Leukemia
116
22.3
12.5
ANLL
63
94.8
14.9
Risks of Second Malignancy following HL
combined
results from 3 large studies* (n=9618)
SIR: Standardized Incidence Ratio; AER: Absolute Excess Risk per 10,000 persons/year
*Based on Hancock 1996; Van Leeuwen 2000; Swerdlow 2000